Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Grant revenue $ 86,047 $ 131,521
Operating expenses:        
Research and development 2,824,598 3,547,321 10,595,842 9,275,800
General and administrative 1,215,009 847,134 3,590,892 4,194,103
Total operating expenses 4,039,607 4,394,455 14,186,734 13,469,903
Loss from operations (3,953,560) (4,394,455) (14,055,213) (13,469,903)
Other income (expense):        
Interest income 41,634 17,760 68,909 62,047
Interest expense (5,228) (7,053) (9,290) (10,654)
Local business tax (489) 2 (1,469) (1,198)
Miscellaneous income 11,333 670
Total other income, net 35,917 10,709 69,483 50,865
Loss before income taxes (3,917,643) (4,383,746) (13,985,730) (13,419,038)
Income tax benefit
Net loss $ (3,917,643) $ (4,383,746) $ (13,985,730) $ (13,419,038)
Basic and diluted net loss per share $ (0.03) $ (0.04) $ (0.12) $ (0.12)
Shares used to compute basic and diluted net loss per share 116,744,807 116,262,938 116,511,473 111,748,586